Northern Trust Corp Neogenomics Inc Transaction History

Northern Trust Corp

  • $572 Billion
  • Q1 2024

A detailed history of Northern Trust Corp transactions in Neogenomics Inc stock. As of the latest transaction made, Northern Trust Corp holds 1,527,216 shares of NEO stock, worth $20.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,527,216
Previous 1,598,640 4.47%
Holding current value
$20.9 Million
Previous $25.9 Million 7.18%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$14.06 - $16.79 $1 Million - $1.2 Million
-71,424 Reduced 4.47%
1,527,216 $24 Million
Q4 2023

Feb 13, 2024
BUY
$11.67 - $20.73 $262,551 - $466,383
22,498 Added 1.43%
1,598,640 $25.9 Million
Q3 2023

Nov 13, 2023
BUY
$12.15 - $17.85 $10,060 - $14,779
828 Added 0.05%
1,576,142 $19.4 Million
Q2 2023

Aug 11, 2023
BUY
$14.1 - $19.83 $368,108 - $517,701
26,107 Added 1.69%
1,575,314 $25.3 Million
Q1 2023

May 15, 2023
SELL
$9.09 - $19.45 $66,438 - $142,160
-7,309 Reduced 0.47%
1,549,207 $27 Million
Q4 2022

Feb 13, 2023
SELL
$6.45 - $12.07 $545,392 - $1.02 Million
-84,557 Reduced 5.15%
1,556,516 $14.4 Million
Q3 2022

Nov 14, 2022
BUY
$7.86 - $12.91 $3.01 Million - $4.94 Million
382,486 Added 30.39%
1,641,073 $14.1 Million
Q2 2022

Aug 12, 2022
SELL
$7.06 - $13.97 $1.74 Million - $3.44 Million
-246,477 Reduced 16.38%
1,258,587 $10.3 Million
Q1 2022

May 13, 2022
SELL
$12.15 - $35.28 $579,214 - $1.68 Million
-47,672 Reduced 3.07%
1,505,064 $18.3 Million
Q4 2021

Feb 08, 2022
SELL
$30.49 - $48.49 $434,939 - $691,709
-14,265 Reduced 0.91%
1,552,736 $53 Million
Q3 2021

Nov 15, 2021
SELL
$41.66 - $52.52 $644,188 - $812,116
-15,463 Reduced 0.98%
1,567,001 $75.6 Million
Q2 2021

Aug 13, 2021
BUY
$36.62 - $51.69 $478,550 - $675,484
13,068 Added 0.83%
1,582,464 $71.5 Million
Q1 2021

May 12, 2021
BUY
$41.56 - $59.88 $845,579 - $1.22 Million
20,346 Added 1.31%
1,569,396 $75.7 Million
Q4 2020

Feb 11, 2021
SELL
$36.08 - $56.47 $28,467 - $44,554
-789 Reduced 0.05%
1,549,050 $83.4 Million
Q3 2020

Nov 16, 2020
SELL
$33.26 - $40.48 $2.26 Million - $2.75 Million
-67,825 Reduced 4.19%
1,549,839 $57.2 Million
Q2 2020

Aug 14, 2020
BUY
$24.21 - $31.02 $3.54 Million - $4.54 Million
146,388 Added 9.95%
1,617,664 $50.1 Million
Q1 2020

May 14, 2020
SELL
$20.5 - $34.53 $2.42 Million - $4.07 Million
-117,944 Reduced 7.42%
1,471,276 $40.6 Million
Q4 2019

Feb 14, 2020
SELL
$18.96 - $29.84 $783,787 - $1.23 Million
-41,339 Reduced 2.54%
1,589,220 $46.5 Million
Q3 2019

Nov 13, 2019
BUY
$19.12 - $26.24 $3.59 Million - $4.93 Million
187,806 Added 13.02%
1,630,559 $31.2 Million
Q2 2019

Aug 13, 2019
BUY
$19.57 - $24.1 $1.25 Million - $1.53 Million
63,660 Added 4.62%
1,442,753 $31.7 Million
Q1 2019

May 13, 2019
BUY
$12.14 - $20.46 $2.98 Million - $5.01 Million
245,101 Added 21.61%
1,379,093 $28.2 Million
Q4 2018

Feb 12, 2019
SELL
$11.24 - $18.5 $123,122 - $202,649
-10,954 Reduced 0.96%
1,133,992 $14.3 Million
Q3 2018

Nov 14, 2018
BUY
$12.5 - $15.38 $1.83 Million - $2.25 Million
146,139 Added 14.63%
1,144,946 $17.6 Million
Q2 2018

Sep 18, 2018
SELL
$7.99 - $14.05 $41,388 - $72,779
-5,180 Reduced 0.52%
998,807 $13.1 Million
Q2 2018

Aug 14, 2018
BUY
$7.99 - $14.05 $211,519 - $371,945
26,473 Added 2.71%
1,003,987 $13.2 Million
Q1 2018

May 09, 2018
BUY
$7.23 - $8.76 $93,411 - $113,179
12,920 Added 1.34%
977,514 $7.98 Million
Q4 2017

Feb 14, 2018
SELL
$8.02 - $11.18 $127,437 - $177,650
-15,890 Reduced 1.62%
964,594 $8.55 Million
Q3 2017

Nov 13, 2017
BUY
$9.11 - $11.26 $8.93 Million - $11 Million
980,484
980,484 $10.9 Million

Others Institutions Holding NEO

# of Institutions
279
Shares Held
127M
Call Options Held
1.13M
Put Options Held
232K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.72B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email